Genmark Diagnostics (GNMK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -18,644 | -14,920 | -11,692 | -7,008 | -47,350 |
| Depreciation Amortization | 9,580 | 7,276 | 4,658 | 2,407 | 8,875 |
| Accounts receivable | -4,105 | 376 | -1,866 | -8,979 | -5,584 |
| Accounts payable and accrued liabilities | 5,224 | 7,382 | 3,598 | -1,558 | 1,501 |
| Other Working Capital | -294 | 2,376 | -2,196 | -9,008 | -12,003 |
| Other Operating Activity | 14,373 | 4,181 | 7,883 | 16,541 | 19,635 |
| Operating Cash Flow | $6,134 | $6,671 | $385 | $-7,605 | $-34,926 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -78,733 | -70,477 | -41,275 | -11,713 | -80 |
| PPE Investments | -17,776 | -7,874 | -1,703 | -952 | -2,092 |
| Investing Cash Flow | $-96,509 | $-78,351 | $-42,978 | $-12,665 | $-2,172 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 0 | 0 | 70,000 |
| Debt Repayment | -57 | -45 | -33 | -23 | -35,093 |
| Common Stock Issued | 87,727 | 86,184 | 81,653 | 2,263 | 13,904 |
| Other Financing Activity | -100 | -100 | -100 | -100 | -3,638 |
| Financing Cash Flow | $87,570 | $86,039 | $81,520 | $2,140 | $45,173 |
| Exchange Rate Effect | -95 | -22 | 22 | 31 | -1 |
| Beginning Cash Position | 45,118 | 45,118 | 45,118 | 45,118 | 37,044 |
| End Cash Position | 42,218 | 59,455 | 84,067 | 27,019 | 45,118 |
| Net Cash Flow | $-2,900 | $14,337 | $38,949 | $-18,099 | $8,074 |
| Free Cash Flow | |||||
| Operating Cash Flow | 6,134 | 6,671 | 385 | -7,605 | -34,926 |
| Capital Expenditure | -17,776 | -7,874 | -1,703 | -952 | -2,092 |
| Free Cash Flow | -11,642 | -1,203 | -1,318 | -8,557 | -37,018 |